Clinical and Payment Policies
Please note that all policies posted on this page apply to members and providers participating in the Meridian Medicaid Plan and may be posted with either a “Meridian” or “Centene” heading.
Clinical Policies
Clinical policies are guidelines used to help administer health plan benefits, either by prior authorization or payment rules. They include (but are not limited to) policies related to evolving medical technologies and procedures, and pharmacy policies. Amendments, modifications, supplements to these policies, and/or additional policies are regularly posted.
For specific services, Meridian may delegate utilization management to a vendor partner. In these circumstances, we may use the delegated vendor’s guidelines to support medical necessity and other coverage determinations. Review the Provider Manual and visit our Prior Authorization page for information about Meridian vendor solution partners.
- Abdominoplasty, Panniculectomy, Suction Lipectomy, Lipoabdominoplasty Requests (CP.MP.109) (PDF)
- Air Ambulance (CP.MP.175) (PDF)
- Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-Thalassemia (CP.MP.108) (PDF)
- Allogeneic Pancreatic Islet Cellular Therapy (CP.MP.250) (PDF)
- Articular Cartilage Defect Repairs (CP.MP.26) (PDF)
- Assisted Reproductive Technology (CP.MP.55) (PDF)
- Attention Deficit Hyperactivity Disorder Assessment and Treatment (CP.MP.124) (PDF)
- Assisted Reproductive Technology (CP.MP.55) (PDF)
- Bariatric Surgery (CP.MP.37) (PDF)
- Behavioral Health Treatment Documentation Requirements (CP.BH.500) (PDF)
- Biofeedback (CP.MP.168) (PDF)
- Bone-Anchored Hearing Aid (CP.MP.93) (PDF)
- Brand Name Override (CP.PMN.22) (PDF)
- Brexpiprazole (Rexulti) (CP.PMN.68) (PDF)
- Burn Surgery (CP.MP.186) (PDF)
- Calcifediol (Rayaldee) (CP.PMN.76) (PDF)
- Calcipotriene/Betamethasone Dipropionate Foam (Enstilar) (CP.PMN.181) (PDF)
- Carrier Screening in Pregnancy (CP.MP.234) (PDF)
- Caudal or Interlaminar Epidural Steroid Injections (CP.MP.164) (PDF)
- Cell-free Fetal DNA Testing (CP.MP.231) (PDF)
- Chiropractic Care (IL.CP.MP.535) (PDF)
- Cochlear Implant Replacements (CP.MP.14) (PDF)
- Concert Genetics Genetic Testing: Aortopathies and Connective Tissue Disorders (PDF)
- Concert Genetics Genetic Testing: Cardiac Disorders (PDF)
- Concert Genetics Genetic Testing: Dermatologic Conditions (PDF)
- Concert Genetics Genetic Testing: Epilepsy, Neurodegenerative, and Neuromuscular Conditions (PDF)
- Concert Genetics Genetic Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (PDF)
- Concert Genetics Genetic Testing: Eye Disorders (PDF)
- Concert Genetics Genetic Testing: Gastroenterologic Disorders (noncancerous) (PDF)
- Concert Genetics Genetic Testing: General Approach to Genetic and Molecular Testing (PDF)
- Concert Genetics Genetic Testing: Hearing Loss (PDF)
- Concert Genetics Genetic Testing: Hematologic Conditions (non-cancerous) (PDF)
- Concert Genetics Genetic Testing: Hereditary Cancer Susceptibility (PDF)
- Concert Genetics Genetic Testing: Immune, Autoimmune, and Rheumatoid Disorders (PDF)
- Concert Genetics Genetic Testing: Kidney Disorders (PDF)
- Concert Genetics Genetic Testing: Lung Disorders (PDF)
- Concert Genetics Genetic Testing: Metabolic, Endocrine, and Mitochondrial Disorders (PDF)
- Concert Genetics Genetic Testing: Multisystem Inherited Disorders, Intellectual Disability, and Developmental Delay (PDF)
- Concert Genetics Genetic Testing: Non-invasive Prenatal Screening (NIPS) (PDF)
- Concert Genetics Oncology: Algorithmic Testing (PDF)
- Concert Genetics Oncology: Cancer Screening (PDF)
- Concert Genetics Oncology: Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy) (PDF)
- Concert Genetics Oncology: Cytogenetic Testing (PDF)
- Concert Genetics Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (PDF)
- Concert Genetics Genetic Testing: Pharmacogenetics (PDF)
- Concert Genetics Genetic Testing: Preimplantation Genetic Testing (PDF)
- Concert Genetics Genetic Testing: Prenatal and Preconception Carrier Screening (PDF)
- Concert Genetics Genetic Testing: Prenatal Diagnosis (via Amniocentesis, CVS, or PUBS) and Pregnancy Loss (PDF)
- Concert Genetics Genetic Testing: Skeletal Dysplasia and Rare Bone Disorders (PDF)
- Continuous Glucose Monitor (MDN.CP.PMN.214) (PDF)
- Diaphragmatic/Phrenic Nerve Stimulation (CP.MP.203) (PDF)
- Disc Decompression Procedures (CP.MP.114) (PDF)
- Discography (CP.MP.115) (PDF)
- Donor Lymphocyte Infusion (CP.MP.101) (PDF)
- Drugs of Abuse: Definitive Testing (CP.MP.50) (PDF)
- Durable Medical Equipment and Orthotics and Prosthetics Guidelines (CP.MP.107) (PDF)
- Elective Abortion (IL.CP.MP.509) (PDF)
- Electric Tumor Treating Fields (Optune) (CP.MP.145) (PDF)
- Experimental Technologies (CP.MP.36) (PDF)
- Facet Joint Interventions (CP.MP.171) (PDF)
- Facility-based Sleep Studies for Obstructive Sleep Apnea (CP.MP.248) (PDF)
- Fecal Incontinence Treatments (CP.MP.137) (PDF)
- Ferriscan R2-MRI (CP.MP.53) (PDF)
- Fertility Preservation (CP.MP.130) (PDF)
- Fetal Surgery in Utero for Prenatally Diagnosed Malformations (CP.MP.129) (PDF)
- Functional MRI (CP.MP.43) (PDF)
- Gastric Electrical Stimulation (CP.MP.40) (PDF)
- Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing (CP.MP.209) (PDF)
- Gender Affirming Surgery for the Treatment of Gender Dysphoria in Adults (IL.CP.MP.558) (PDF)
- Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing (CP.MP.209) (PDF)
- Genetic and Molecular Testing Services (CG.PP.551) (PDF)
- Heart-Lung Transplant (CP.MP.132) (PDF)
- Hematopoietic Cell Transplantation in Sickle Cell Disease (IL.CP.MP.554) (PDF)
- Holter Monitors (CP.MP.113) (PDF)
- Home Births (CP.MP.136) (PDF)
- Home INR Monitor (IL.CP.MP.502) (PDF)
- Home Ventilators (CP.MP.184) (PDF)
- Homocysteine Testing (CP.MP.121) (PDF)
- Hospice Services (CP.MP.54) (PDF)
- Hyperbaric Oxygen Therapy (IL.CP.MP.552) (PDF)
- Hyperhidrosis Treatments (CP.MP.62) (PDF)
- Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (CP.MP.180) (PDF)
- Implantable Intrathecal or Epidural Pain Pump (CP.MP.173) (PDF)
- Implantable Loop Recorder (CP.MP.243) (PDF)
- Implantable Wireless Pulmonary Artery Pressure Monitoring (CP.MP.160) (PDF)
- Infectious Disease: Dermatologic Lab Testing (CG.CP.MP.03) (PDF)
- Infectious Disease: Gastroenterologic Lab Testing (CG.CP.MP.04) (PDF)
- Infectious Disease: Genitourinary Lab Testing (CG.CP.MP.07) (PDF)
- Infectious Disease: Multisystem Lab Testing (CG.CP.MP.02) (PDF)
- Infectious Disease: Primary Care & Preventive Lab Screening (CG.CP.MP.05) (PDF)
- Infectious Disease: Respiratory Lab Testing (CG.CP.MP.01) (PDF)
- Infectious Disease: Vector-borne and Tropical Diseases Lab Testing (CG.CP.MP.06) (PDF)
- Infertility (IL.CP.MP.507) (PDF)
- Initial Bone Marrow Transplant (IL.CP.MP.513) (PDF)
- Intensity-Modulated Radiotherapy (CP.MP.69) (PDF)
- Intestinal and Multivisceral Transplant (CP.MP.58) (PDF)
- Intradiscal Steroid Injections for Pain Management (CP.MP.167) (PDF)
- IV Moderate Sedation, IV Deep Sedation, and General Anesthesia for Dental Procedures (CP.MP.61) (PDF)
- Liposuction for Lipedema (CP.MP.244) (PDF)
- Low-Frequency Ultrasound and Noncontact Normothermic Wound Therapy (CP.MP.139) (PDF)
- Lung Transplantation (CP.MP.57) (PDF)
- Lysis of Epidural Lesions (CP.MP.116) (PDF)
- Mechanical Stretching Devices for Joint Stiffness and Contracture (CP.MP.144) (PDF)
- Medical Necessity Criteria (CP.CPC.05) (PDF)
- Meridian Clinical Policy Readmission Review (IL.CP.MP.550) (PDF)
- Multiple Sleep Latency Testing (CP.MP.24) (PDF)
- Nerve Blocks and Neurolysis for Pain Management (CP.MP.170) (PDF)
- Neuromuscular and Peroneal Nerve Electrical Stimulation (NMES) (CP.MP.48) (PDF)
- Nonmyeloablative Allogeneic Stem Cell Transplants (CP.MP.141) (PDF)
- Omisirge (omidubicel): Nicotinamide-modified allogeneic hematopoietic progenitor cell therapy (CP.MP.249) (PDF)
- Orthognathic Surgery (CP.MP.202) (PDF)
- Osteogenic Stimulation (CP.MP.194) (PDF)
- Outpatient Cardiac Rehabilitation (CP.MP.176) (PDF)
- Outpatient Oxygen Use (CP.MP.190) (PDF)
- Out of Network and Non-Emergent Out of State Services (IL.CP.MP.528) (PDF)
- Palliative Care (IL.CP.MP.553) (PDF)
- Pancreas Transplantation (CP.MP.102) (PDF)
- Panniculectomy (CP.MP.109) (PDF)
- Pediatric Heart Transplant (CP.MP.138) (PDF)
- Pediatric Kidney Transplant (CP.MP.246) (PDF)
- Pediatric Liver Transplant (CP.MP.120) (PDF)
- Pediatric Oral Function Therapy (CP.MP.188) (PDF)
- Percutaneous Left Atrial Appendage Closure Device for Stroke Prevention (CP.MP.147) (PDF)
- Phototherapy for Neonatal Hyperbilirubinemia (CP.MP.150) (PDF)
- Physical, Occupational, and Speech Therapy Services (CP.MP.49) (PDF)
- Physician Advisory Committee (IL.CP.MP.539) (PDF)
- Polymerase Chain Reaction Respiratory Viral Panel Testing (CP.MP.181) (PDF)
- Posterior Tibial Nerve Stimulation for Voiding Dysfunction (CP.MP.133) (PDF)
- Proton and Neutron Beam Therapies (CP.MP.70) (PDF)
- Pulmonary Function Testing (CP.MP.242) (PDF)
- Readmission Review (IL.CP.MP.505) (PDF)
- Reduction Mammoplasty and Gynecomastia Surgery (CP.MP.51) (PDF)
- Relizorb (IL.CP.MP.504) (PDF)
- Repair of Nasal Valve Compromise (CP.MP.210) (PDF)
- Review of Non-Emergent Out of State Services (IL.CP.MP.528) (PDF)
- Sacroiliac Joint Fusion (CP.MP.126) (PDF)
- Sacroiliac Joint Interventions for Pain Management (CP.MP.166) (PDF)
- Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders (CP.MP.146) (PDF)
- Selective Dorsal Rhizotomy for Spasticity in Cerebral Palsy (CP.MP.174) (PDF)
- Selective Nerve Root Blocks and Transforaminal Epidural Steroid Injections (CP.MP.165) (PDF)
- Serious Reportable Events Hospital Acquired Conditions Other Provider Preventable Conditions (IL.CP.MP.533) (PDF)
- Short Inpatient Hospital Stay (CP.MP.182) (PDF)
- Skin and Soft Tissue Substitutes for Chronic Wounds (CP.MP.185) (PDF)
- Specialized Lenses (IL.CP.MP.503) (PDF)
- Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation (CP.MP.117) (PDF)
- Stereotactic Body Radiation Therapy (CP.MP.22) (PDF)
- Sterilization (IL.CP.MP.519) (PDF)
- Tandem Transplant (CP.MP.162) (PDF)
- Testing for Select Genitourinary Conditions (CP.MP.97) (PDF)
- Thyroid Hormones and Insulin Testing in Pediatrics (CP.MP.154) (PDF)
- Total Artificial Heart (CP.MP.127) (PDF)
- Total Parenteral Nutrition and Intradialytic Parenteral Nutrition (CP.MP.163) (PDF)
- Transplant Service Documentation Requirements (CP.MP.247) (PDF)
- Transcatheter Closure of Patent Foramen Ovale (CP.MP.151) (PDF)
- Transplant Service Documentation Requirements (CP.MP.247) (PDF)
- Trigger Point Injections for Pain Management (CP.MP.169) (PDF)
- Urinary Incontinence Devices and Treatments (CP.MP.142) (PDF)
- Urodynamic Testing (CP.MP.98) (PDF)
- Vagus Nerve Stimulation(CP.MP.12) (PDF)
- Ventricular Assist Devices (CP.MP.46) (PDF)
- Wireless Motility Capsule (CP.MP.143) (PDF)
Effective 12/1/24
- Abdominoplasty, Panniculectomy, Suction Lipectomy, Lipoabdominoplasty Requests (PDF)
- Carrier Screening in Pregnancy (PDF)
- Cell-free Fetal DNA Testing (PDF)
- Continuous Glucose Monitoring (PDF)
- Fecal Microbiota Transplant (PDF)
- Genetic Testing (PDF)
- Hematopoietic Cell Transplantation in Sickle Cell Disease (PDF)
- Initial Bone Marrow Transplant (PDF)
- Heart Transplant (PDF)
- Home Birth (PDF)
- Hospice Services (PDF)
- Hyperbaric Oxygen Therapy (PDF)
- Liver Transplant (PDF)
- Medical Weight Loss Management (PDF)
- Member Compliance Medical Policy (PDF)
- Monochromatic Infrared Energy (PDF)
- Occupational Therapy (PDF)
- Orthognathic Surgery (PDF)
- Physical Therapy (PDF)
- Substance Abuse Withdrawal and Intoxication Management (PDF)
- Transplant Evaluation (PDF)
- Urgent and Emergent Care (PDF)
- Ventricular Assist Devices (PDF)
Pharmacy Policies
Meridian is committed to supplying high-quality, cost-effective drug therapy to all members. Meridian pharmacy policies aid in administering benefits by delineating prior authorization or payment rules. Consult our Pharmacy page for the current Meridian Preferred Drug List (PDL).
- Abaloparatide (Tymlos) (IL.PHAR.345) (PDF)
- Abatacept (Orencia) (MDN.CP.PHAR.241) (PDF)
- Abemaciclib (Verzenio) (CP.PHAR.355) (PDF)
- Abiraterone (Zytiga, Yonsa) (CP.PHAR.84) (PDF)
- AbobotulinumtoxinA (Dysport) (CP.PHAR.230) (PDF)
- Abrocitinib (Cibinqo) (CP.PHAR.578) (PDF)
- Acalabrutinib (Calquence) (CP.PHAR.366) (PDF)
- Acitretin (Soriatane) (CP.PMN.40) (PDF)
- Acyclovir Buccal Tablet (Sitavig) (CP.PMN.210) (PDF)
- Adagrasib (Krazati) (CP.PHAR.605) (PDF)
- Adalimumab (Humira), Adalimumab-atto (Amjevita), Adalimumab-adbm (Cyltezo), Adalimumab-bwwd (Hadlima), Adalimumabadaz (Hyrimoz), Adalimumab-aacf (Idacio), Adalimumab-aaty (Yuflyma), Adalimumab-aqvh (Yusimry) (MDN.CP.PHAR.242) (PDF)
- Adefovir (Hepsera) (MDN.CP.PHAR.142) (PDF)
- Ado-Trastuzumab Emtansine (Kadcyla) (CP.PHAR.229) (PDF)
- Aducanumab-avwa (Aduhelm) (CP.PHAR.468) (PDF)
- Afamelanotide (Scenesse) (CP.PHAR.444) (PDF)
- Afatinib (Gilotrif) (CP.PHAR.298) (PDF)
- Aflibercept (Eylea) (CP.PHAR.184) (PDF)
- Agalsidase Beta (Fabrazyme) (CP.PHAR.158) (PDF)
- Alectinib (Alecensa) (CP.PHAR.369) (PDF)
- Alemtuzumab (Lemtrada) (MDN.CP.PHAR.243) (PDF)
- Alglucosidase Alfa (Lumizyme) (CP.PHAR.160) (PDF)
- Alirocumab (Praluent) (CP.PHAR.124) (PDF)
- Alosetron (Lotronex) (CP.PMN.153) (PDF)
- Alpelisib (Piqray) (CP.PHAR.430) (PDF)
- Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) (CP.PHAR.94) (PDF)
- Amantadine ER (Gocovri, Osmolex ER) (MDN.CP.PMN.89) (PDF)
- Ambrisentan (Letairis) (MDN.CP.PHAR.190) (PDF)
- Amifampridine (Firdapse, Ruzurgi) (MDN.CP.PHAR.411) (PDF)
- Amikacin (Arikayce) (CP.PHAR.401) (PDF)
- Amivantamab-vmjw (Rybrevant) (CP.PHAR.544) (PDF)
- Anakinra (Kineret) (MDN.CP.PHAR.244) (PDF)
- Anifrolumab-fnia (Saphnelo) (CP.PHAR.551) (PDF)
- Anti-Inhibitor Coagulant Complex, Human (Feiba) (CP.PHAR.217) (PDF)
- Antithrombin III (ATryn, Thrombate III) (CP.PHAR.564) (PDF)
- Antithymocyte Globulin (Atgam, Thymoglobulin) (CP.PHAR.506) (PDF)
- Apalutamide (Erleada) (CP.PHAR.376) (PDF)
- Apixaban (Eliquis®) (MDN.CP.PMN.300) (PDF)
- Apomorphine (Apokyn, Kynmobi) (CP.PHAR.488) (PDF)
- Apremilast (Otezla) (MDN.CP.PHAR.245) (PDF)
- Aripiprazole Long-Acting Injections (Abilify Maintena, Abilify Asimtufii, Aristada, Aristada Initio) (MDN.CP.PHAR.290) (PDF)
- Armodafinil (Nuvigil) (MDN.CP.PMN.35) (PDF)
- Asciminib (Scemblix) (CP.PHAR.565) (PDF)
- Asenapine (Saphris, Secuado) (CP.PMN.15) (PDF)
- Asfotase Alfa (Strensiq) (CP.PHAR.328) (PDF)
- Atezolizumab (Tecentriq) (CP.PHAR.235) (PDF)
- Atogepant (Qulipta) (MDN.CP.PHAR.566) (PDF)
- Avacopan (Tavneos) (CP.PHAR.515) (PDF)
- Avalglucosidase Alfa-ngpt (Nexviazyme) (CP.PHAR.521) (PDF)
- Avapritinib (Ayvakit) (CP.PHAR.454) (PDF)
- Avatrombopag (Doptelet) (CP.PHAR.130) (PDF)
- Avelumab (Bavencio) (CP.PHAR.333) (PDF)
- Axitinib (Inlyta) (CP.PHAR.100) (PDF)
- Azacitidine (Onureg, Vidaza) (CP.PHAR.387) (PDF)
- Aztreonam (Cayston) (MDN.CP.PHAR.209) (PDF)
- Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) (CP.PHAR.149) (PDF)
- Baloxavir Marboxil (Xofluza) (CP.PMN.185) (PDF)
- Baricitinib (Olumiant) (MDN.CP.PHAR.135) (PDF)
- Bedaquiline (Sirturo) (CP.PMN.212) (PDF)
- Belantamab Mafodotin (Blenrep) (CP.PHAR.469) (PDF)
- Belatacept (Nulojix) (CP.PHAR.201) (PDF)
- Belimumab (Benlysta) (CP.PHAR.88) (PDF)
- Belinostat (Beleodaq) (CP.PHAR.311) (PDF)
- Belumosudil (Rezurock) (CP.PHAR.552) (PDF)
- Belzutifan (Welireg) (CP.PHAR.553) (PDF)
- Bendamustine (Belrapzo, Bendeka, Treanda) (CP.PHAR.307) (PDF)
- Benralizumab (Fasenra) (MDN.CP.PHAR.373) (PDF)
- Benznidazole (CP.PMN.90) (PDF)
- Berotralstat (Orladeyo) (MDN.CP.PHAR.485) (PDF)
- Betaine (Cystadane) (CP.PHAR.143) (PDF)
- Betamethasone Dipropionate Spray (Sernivo) (MDN.CP.PMN.182) (PDF)
- Bevacizumab (Avastin, Mvasi, Zirabev) (CP.PHAR.93) (PDF)
- Bexarotene (Targretin Capsules, Gel) (CP.PHAR.75) (PDF)
- Bezlotoxumab (Zinplava) (CP.PHAR.300) (PDF)
- Bimatoprost Implant (Durysta) (CP.PHAR.486) (PDF)
- Binimetinib (Mektovi) (CP.PHAR.50) (PDF)
- Blinatumomab (Blincyto) (CP.PHAR.312) (PDF)
- Bortezomib (Velcade) (CP.PHAR.410) (PDF)
- Bosentan (Tracleer) (CP.PHAR.191) (PDF)
- Bosutinib (Bosulif) (CP.PHAR.105) (PDF)
- Brentuximab Vedotin (Adcetris) (CP.PHAR.303) (PDF)
- Brexanolone (Zulresso) (CP.PHAR.417) (PDF)
- Brigatinib (Alunbrig) (CP.PHAR.342) (PDF)
- Brodalumab (Siliq) (CP.PHAR.375) (PDF)
- Brolucizumab-dbll (Beovu) (CP.PHAR.445) (PDF)
- Budesonide (Tarpeyo) (CP.PHAR.572) (PDF)
- Burosumab-twza (Crysvita) (CP.PHAR.11) (PDF)
- C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (MDN.CP.PHAR.202) (PDF)
- Cabazitaxel (Jevtana) (CP.PHAR.316) (PDF)
- Cabotegravir/Rilpivirine (Cabenuva) (MDN.CP.PHAR.573) (PDF)
- Cabozantinib (Cabometyx, Cometriq) (CP.PHAR.111) (PDF)
- Canakinumab (Ilaris) (CP.PHAR.246) (PDF)
- Cannabidiol (Epidiolex) (MDN.CP.PMN.164) (PDF)
- Capecitabine (Xeloda) (CP.PHAR.60) (PDF)
- Caplacizumab-yhdp (Cablivi) (CP.PHAR.416) (PDF)
- Capmatinib (Tabrecta) (CP.PHAR.494) (PDF)
- Carbidopa/Levodopa ER Capsules (Rytary), Enteral Suspension (Duopa), IR Tablets (Dhivy) (CP.PMN.238) (PDF)
- Carfilzomib (Kyprolis) (CP.PHAR.309) (PDF)
- Carglumic Acid (Carbaglu) (CP.PHAR.206) (PDF)
- Cariprazine (Vraylar) (CP.PMN.91) (PDF)
- Casimersen (Amondys 45) (MDN.CP.PHAR.470) (PDF)
- Celecoxib (Celebrex, Elyxyb) (MDN.CP.PMN.122) (PDF)
- Cemiplimab-rwlc (Libtayo) (CP.PHAR.397) (PDF)
- Cenegermin-bkbj (Oxervate) (CP.PMN.186) (PDF)
- Cenobamate (Xcopri) (MDN.CP.PMN.231) (PDF)
- Ceritinib (Zykadia) (CP.PHAR.349) (PDF)
- Cerliponase Alfa (Brineura) (CP.PHAR.338) (PDF)
- Certolizumab (Cimzia) (MDN.CP.PHAR.247) (PDF)
- Cetuximab (Erbitux) (CP.PHAR.317) (PDF)
- Chenodiol (Chenodal) (CP.PMN.239) (PDF)
- Chlorambucil (Leukeran) (CP.PHAR.554) (PDF)
- Chloramphenicol Sodium Succinate (CP.PHAR.388) (PDF)
- Cholic Acid (Cholbam) (CP.PHAR.390) (PDF)
- Ciclopirox (Penlac) (CP.PMN.24) (PDF)
- Ciltacabtagene Autoleucel (CP.PHAR.533) (PDF)
- Cinacalcet (Sensipar) (CP.PHAR.61) (PDF)
- Cladribine (Mavenclad) (MDN.CP.PHAR.422) (PDF)
- Clinical Trials(CP.MP.94) (PDF)
- Clobazam (Onfi, Sympazan) (MDN.CP.PMN.54) (PDF)
- Clozapine Orally Disintegrating Tablet (MDN.CP.PMN.12) (PDF)
- Cobimetinib (Cotellic) (CP.PHAR.380) (PDF)
- Colchicine (Colcrys) (CP.PMN.123) (PDF)
- Colesevelam (Welchol) (MDN.CP.PMN.250) (PDF)
- Collagenase Clostridium Histolyticum (Xiaflex) (CP.PHAR.82) (PDF)
- Copanlisib (Aliqopa) (CP.PHAR.357) (PDF)
- Corticosteroids for Ophthalmic Injection (Iluvien, Ozurdex, Retisert, Xipere, Yutiq) (CP.PHAR.385) (PDF)
- Repository Corticotropin Injection (H.P. Acthar Gel, Purified Cortrophin Gel) (CP.PHAR.168) (PDF)
- Cosmetic and Reconstructive Procedures (CP.MP.31) (PDF)
- Cosmetic Surgery (CP.MP.31) (PDF)
- Cosyntropin (Cortrosyn) (CP.PHAR.203) (PDF)
- Crisaborole (Eucrisa) (MDN.CP.PMN.110) (PDF)
- Crizanlizumab-tmca (Adakveo) (CP.PHAR.449) (PDF)
- Crizotinib (Xalkori) (CP.PHAR.90) (PDF)
- Cyclosporine (Cequa, Restasis, Verkazia) (CP.PMN.48) (PDF)
- Cysteamine Ophthalmic (Cystaran, Cystadrops) (CP.PMN.130) (PDF)
- Cysteamine oral (Cystagon, Procysbi) (CP.PHAR.155) (PDF)
- Cytomegalovirus Immune Globulin (CytoGam) (CP.PHAR.277) (PDF)
- Dabrafenib (Tafinlar) (CP.PHAR.239) (PDF)
- Dacomitinib (Vizimpro) (CP.PHAR.399) (PDF)
- Dalfampridine (Ampyra) (CP.PHAR.248) (PDF)
- Daptomycin (Cubicin, Cubicin RF) (CP.PHAR.351) (PDF)
- Daratumumab (Darzalex), Daratumumab/Hyaluronidase-fihj (Darzalex Faspro) (CP.PHAR.310) (PDF)
- Darbepoetin Alfa (Aranesp) (MDN.CP.PHAR.236) (PDF)
- Darolutamide (Nubeqa) (CP.PHAR.435) (PDF)
- Dasatinib (Sprycel) (CP.PHAR.72) (PDF)
- Daunorubicin/Cytarabine (Vyxeos) (CP.PHAR.352) (PDF)
- Decitabine/Cedazuridine (Inqovi) (CP.PHAR.479) (PDF)
- Deferasirox (Exjade, Jadenu) (MDN.CP.PHAR.145) (PDF)
- Deferiprone (Ferriprox) (MDN.CP.PHAR.147) (PDF)
- Deferoxamine (Desferal) (CP.PHAR.146) (PDF)
- Deflazacort (Emflaza) (CP.PHAR.331) (PDF)
- Degarelix Acetate (Firmagon) (CP.PHAR.170) (PDF)
- Delafloxacin (Baxdela) (CP.PMN.115) (PDF)
- Denosumab (Prolia, Xgeva) (CP.PHAR.58) (PDF)
- Desmopressin Acetate (DDAVP, Stimate, Nocdurna) (CP.PHAR.214) (PDF)
- Deucravacitinib (Sotyktu) (MDN.CP.PHAR.607) (PDF)
- Deutetrabenazine (Austedo) (MDN.CP.PHAR.341) (PDF)
- Dexrazoxane (Zinecard, Totect) (CP.PHAR.418) (PDF)
- Dextromethorphan/Bupropion (Auvelity) (CP.PMN.284) (PDF)
- Dextromethorphan-Quinidine (Nuedexta) (MDN.CP.PMN.93) (PDF)
- Diazepam Nasal Spray (Valtoco) (MDN.CP.PMN.216) (PDF)
- Dichlorphenamide (Keveyis) (CP.PMN.261) (PDF)
- Diroximel Fumarate (Vumerity), Monomethyl Fumarate (Bafiertam) (MDN.CP.PHAR.249) (PDF)
- Dolasetron (Anzemet) (CP.PMN.141) (PDF)
- Dornase Alfa (Pulmozyme) (CP.PHAR.212) (PDF)
- Dostarlimab-gxly (Jemperli) (CP.PHAR.540) (PDF)
- Doxepin (Silenor) (MDN.CP.PMN.175) (PDF)
- Dronabinol (Marinol, Syndros) (CP.PMN.159) (PDF)
- Dupilumab (Dupixent) (MDN.CP.PHAR.336) (PDF)
- Duplicate Therapy (MDN.CP.PMN.351) (PDF)
- Durvalumab (Imfinzi) (CP.PHAR.339) (PDF)
- Duvelisib (Copiktra) (CP.PHAR.400) (PDF)
- Ecallantide (Kalbitor) (MDN.CP.PHAR.177) (PDF)
- Eculizumab (Soliris) (CP.PHAR.97) (PDF)
- Edaravone (Radicava) (CP.PHAR.343) (PDF)
- Efgartigimod Alfa-fcab (Vyvgart) (CP.PHAR.555) (PDF)
- Elagolix (Orilissa), Elagolix/Estradiol/Norethinedrone (Oriahnn) (MDN.CP.PHAR.136) (PDF)
- Elapegademase-lvlr (Revcovi) (CP.PHAR.419) (PDF)
- Elexacaftor/Ivacaftor/Tezacaftor; Ivacaftor (Trikafta) (CP.PHAR.440) (PDF)
- Eliglustat (Cerdelga) (CP.PHAR.153) (PDF)
- Elosulfase Alfa (Vimizim) (CP.PHAR.162) (PDF)
- Elotuzumab (Empliciti) (CP.PHAR.308) (PDF)
- Eltrombopag (Promacta) (CP.PHAR.180) (PDF)
- Eluxadoline (Viberzi) (CP.PMN.170) (PDF)
- Emapalumab-lzsg (Gamifant) (CP.PHAR.402) (PDF)
- Emicizumab-kxwh (Hemlibra) (MDN.CP.PHAR.370) (PDF)
- Enasidenib (Idhifa) (CP.PHAR.363) (PDF)
- Encorafenib (Braftovi) (CP.PHAR.127) (PDF)
- Enfortumab Vedotin-ejfv (Padcev) (CP.PHAR.455) (PDF)
- Entrectinib (Rozlytrek) (CP.PHAR.441) (PDF)
- Enzalutamide (Xtandi) (CP.PHAR.106) (PDF)
- Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (MDN.CP.PHAR.237) (PDF)
- Eptinezumab-jjmr (Vyepti) (CP.PHAR.489) (PDF)
- Erdafitinib (Balversa) (CP.PHAR.423) (PDF)
- Erenumab-aaoe (Aimovig) (MDN.CP.PHAR.128) (PDF)
- Eribulin Mesylate (Halaven) (CP.PHAR.318) (PDF)
- Erlotinib (Tarceva) (CP.PHAR.74) (PDF)
- Erwinia Asparaginase (Erwinaze, Rylaze) (CP.PHAR.301) (PDF)
- Esketamine (Spravato) (MDN.CP.PMN.199) (PDF)
- Etanercept (Enbrel) (MDN.CP.PHAR.250) (PDF)
- Etelcalcetide (Parsabiv) (CP.PHAR.379) (PDF)
- Eteplirsen (Exondys 51) (MDN.CP.PHAR.288) (PDF)
- Everolimus (Afinitor, Afinitor Disperz, Zortress) (CP.PHAR.63) (PDF)
- Evinacumab-dgnb (Evkeeza) (CP.PHAR.511) (PDF)
- Evolocumab (Repatha) (CP.PHAR.123) (PDF)
- Factor IX Complex, Human (Profilnine) (CP.PHAR.219) (PDF)
- Factor IX (Human, Recombinant) (CP.PHAR.218) (PDF)
- Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (CP.PHAR.220) (PDF)
- Factor VIII (Human, Recombinant) (MDN.CP.PHAR.215) (PDF)
- Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) (CP.PHAR.216) (PDF)
- Factor XIII, Human (Corifact) (CP.PHAR.221) (PDF)
- Factor XIII A-Subunit, Recombinant (Tretten) (CP.PHAR.222) (PDF)
- Fam-Trastuzumab Deruxtecan-nxki (Enhertu) (CP.PHAR.456) (PDF)
- Faricimab-svoa (Vabysmo) (CP.PHAR.581) (PDF)
- Febuxostat (Uloric) (CP.PMN.57) (PDF)
- Fedratinib (Inrebic) (CP.PHAR.442) (PDF)
- Fentanyl IR (Abstral, Actiq, Fentora, Lazanda, Subsys) (CP.PMN.127) (PDF)
- Ferric Carboxymaltose (Injectafer) (CP.PHAR.234) (PDF)
- Ferric Derisomaltose (Monoferric) (CP.PHAR.480) (PDF)
- Ferric Gluconate (Ferrlecit) (CP.PHAR.166) (PDF)
- Ferumoxytol (Feraheme) (CP.PHAR.165) (PDF)
- Filgrastim (Neupogen), Filgrastim-sndz (Zarxio), Tbofilgrastim (Granix), Filgrastim-aafi (Nivestym), Filgrastim-ayow (Releuko) (MDN.CP.PHAR.297) (PDF)
- Fingolimod (Gilenya, Tascenso ODT) (MDN.CP.PHAR.251) (PDF)
- Finerone (Kerendia) (CP.PMN.266) (PDF)
- Fosdenopterin (Nulibry) (CP.PHAR.471) (PDF)
- Fostamatinib (Tavalisse) (CP.PHAR.24) (PDF)
- Fremanezumab-vfrm (Ajovy) (MDN.CP.PHAR.403) (PDF)
- Fulvestrant (Faslodex Injection) (CP.PHAR.424) (PDF)
- Gabapentin ER (Gralise, Horizant) (CP.PMN.170) (PDF)
- Galcanezumab-gnlm (Emgality) (MDN.CP.PHAR.404) (PDF)
- Galsulfase (Naglazyme) (CP.PHAR.161) (PDF)
- Gefitinib (Iressa) (CP.PHAR.68) (PDF)
- Gemtuzumab Ozogamicin (Mylotarg) (CP.PHAR.358) (PDF)
- Gilteritinib (Xospata) (CP.PHAR.412) (PDF)
- Givosiran (Givlaari) (CP.PHAR.457) (PDF)
- Glasdegib (Daurismo) (CP.PHAR.413) (PDF)
- Glaucoma Agents (CP.PMN.286) (PDF)
- Glatiramer Acetate (Copaxone, Glatopa) (MDN.CP.PHAR.252) (PDF)
- Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists (MDN.CP.PMN.183) (PDF)
- Glycerol Phenylbutyrate (Ravicti) (CP.PHAR.207) (PDF)
- Glycopyrronium (Qbrexza) (CP.PMN.177) (PDF)
- Golimumab (Simponi, Simponi Aria) (MDN.CP.PHAR.253) (PDF)
- Golodirsen (Vyondys 53) (MDN.CP.PHAR.453) (PDF)
- Goserelin Acetate (Zoladex) (CP.PHAR.171) (PDF)
- Granisetron (Sancuso, Sustol) (CP.PMN.74) (PDF)
- Guselkumab (Tremfya) (MDN.CP.PHAR.364) (PDF)
- Hemin (Panhematin) (CP.PHAR.181) (PDF)
- Histrelin Acetate (Vantas, Supprelin LA) (CP.PHAR.172) (PDF)
- House Dust Mite Allergen Extract (Odactra) (CP.PMN.111) (PDF)
- Human Growth Hormone (Somapacitan, Somatropin) (MDN.CP.PHAR.517) (PDF)
- Hyaluronate Derivatives (CP.PHAR.05) (PDF)
- Hydroxyprogesterone Caproate (Makena/compound) (MDN.CP.PHAR.14) (PDF)
- Hydroxyurea (Siklos) (CP.PMN.193) (PDF)
- Ibalizumab-uiyk (Trogarzo) (MDN.CP.PHAR.378) (PDF)
- Ibandronate Injection (Boniva) (CP.PHAR.189) (PDF)
- Ibandronate Oral (Boniva) (CP.PMN.96) (PDF)
- Ibrutinib (Imbruvica) (CP.PHAR.126) (PDF)
- Icatibant (Firazyr) (MDN.CP.PHAR.178) (PDF)
- Icosapent Ethyl (Vascepa) (MDN.CP.PMN.187) (PDF)
- Idecabtagene Vicleucel (Abecma) (CP.PHAR.481) (PDF)
- Idelalisib (Zydelig) (CP.PHAR.133) (PDF)
- Idursulfase (Elaprase) (CP.PHAR.156) (PDF)
- Iloperidone (Fanapt) (CP.PMN.32) (PDF)
- Iloprost (Ventavis) (MDN.CP.PHAR.193) (PDF)
- Imatinib (Gleevec) (CP.PHAR.65) (PDF)
- Imiglucerase (Cerezyme) (CP.PHAR.154) (PDF)
- Immune Globulins (CP.PHAR.103) (PDF)
- Inclisiran (Leqvio) (CP.PHAR.568) (PDF)
- IncobotulinumtoxinA (Xeomin) (CP.PHAR.231) (PDF)
- Inebilizumab-cdon (Uplizna) (CP.PHAR.458) (PDF)
- Infigratinib (Truseltiq) (CP.PHAR.547) (PDF)
- Infliximab (Remicade), Infliximab-axxq (Avsola), Infliximab-dyyb (Inflectra), and Infliximab-abda (Renflexis) (CP.PHAR.254) (PDF)
- Inhaled Agents for Asthma and COPD (MDN.CP.PMN.259) (PDF)
- Inhaled Nitric Oxide (CP.MP.87) (PDF)
- Inotersen (Tegsedi) (CP.PHAR.405) (PDF)
- Inotuzumab Ozogamicin (Besponsa) (CP.PHAR.359) (PDF)
- Insulin Delivery Systems (V-Go, Omnipod, InPen) (MDN.CP.PHAR.534) (PDF)
- Interferon Beta-1a (Avonex, Rebif) (MDN.CP.PHAR.255) (PDF)
- Interferon Beta-1b (Betaseron, Extavia) (MDN.CP.PHAR.256) (PDF)
- Interferon Gamma- 1b (Actimmune) (CP.PHAR.52) (PDF)
- Ipilimumab (Yervoy) (CP.PHAR.319) (PDF)
- Irinotecan Liposome (Onivyde) (CP.PHAR.304) (PDF)
- Isatuximab-irfc (Sarclisa) (CP.PHAR.482) (PDF)
- Isotretinoin (Absorica, Absorica LD, Amnesteem, Claravis, Myorisan, Zenatane) (CP.PMN.143) (PDF)
- Ivabradine (Corlanor) (CP.PMN.70) (PDF)
- Ivacaftor (Kalydeco) (CP.PHAR.210) (PDF)
- Ivosidenib (Tibsovo) (CP.PHAR.137) (PDF)
- Ixazomib (Ninlaro) (CP.PHAR.302) (PDF)
- Ixekizumab (Taltz) (MDN.CP.PHAR.257) (PDF)
- Lanreotide (Somatuline Depot) (MDN.CP.PHAR.391) (PDF)
- Lapatinib (Tykerb) (CP.PHAR.79) (PDF)
- Laronidase (Aldurazyme) (CP.PHAR.152) (PDF)
- Larotrectinib (Vitrakvi) (CP.PHAR.414) (PDF)
- Lasmiditan (Reyvow) (MDN.CP.PMN.218) (PDF)
- Latanoprostene Bunod (Vyzulta) (CP.PMN.108) (PDF)
- Lecanemab-irmb (Leqembi) (CP.PHAR.596) (PDF)
- Lefamulin (Xenleta) (CP.PMN.219) (PDF)
- Lenalidomide (Revlimid) (CP.PHAR.71) (PDF)
- Lenvatinib (Lenvima) (CP.PHAR.138) (PDF)
- Letermovir (Prevymis) (CP.PHAR.367) (PDF)
- Leucovorin Injection (CP.PHAR.393) (PDF)
- Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) (CP.PHAR.173) (PDF)
- Levoleucovorin (Fusilev, Khapzory) (CP.PHAR.151) (PDF)
- L-glutamine (Endari) (CP.PMN.116) (PDF)
- Linaclotide (Linzess) (MDN.CP.PMN.71) (PDF)
- Linezolid (Zyvox) (CP.PMN.27) (PDF)
- Lisocabtagene Maraleucel (Breyanzi) (CP.PHAR.483) (PDF)
- Lomitapide (Juxtapid) (CP.PHAR.283) (PDF)
- Lomustine (Gleostine) (CP.PHAR.507) (PDF)
- Lonafarnib (Zokinvy) (CP.PHAR.499) (PDF)
- Loncastuximab Tesirine-lpyl (Zynlonta) (CP.PHAR.539) (PDF)
- Long-term Antibiotic Treatment for Tick-borne Diseases (CP.PMN.279) (PDF)
- Lorlatinib (Lorbrena) (CP.PHAR.406) (PDF)
- Loteprednol etabonate (Eysuvis) (CP.PMN.260) (PDF)
- Luliconazole Cream (Luzu) (CP.PMN.166) (PDF)
- Lumacaftor/Ivacaftor (Orkambi) (CP.PHAR.213) (PDF)
- Lumasiran (Oxlumo) (CP.PHAR.473) (PDF)
- Lumateperone (Caplyta) (CP.PMN.232) (PDF)
- Lurasidone (Latuda) (CP.PMN.50) (PDF)
- Lurbinectedin (Zepzelca) (CP.PHAR.500) (PDF)
- Luspatercept-aamt (Reblozyl) (CP.PHAR.450) (PDF)
- Lusutrombopag (Mulpleta) (CP.PHAR.407) (PDF)
- Lutetium Lu 177 dotatate (Lutathera) (CP.PHAR.384) (PDF)
- Macitentan (Opsumit) (CP.PHAR.194) (PDF)
- Maralixibat (Livmarli) (CP.PHAR.543) (PDF)
- Margetuximab-cmkb (Margenza) (CP.PHAR.522) (PDF)
- Mavacamten (Camzyos) (CP.PMN.272) (PDF)
- Mecasermin (Increlex) (CP.PHAR.150) (PDF)
- Mechlorethamine Gel (Valchlor) (CP.PHAR.381) (PDF)
- Megestrol Acetate (Megace ES) (CP.PMN.179) (PDF)
- Melphalan flufenamide (Pepaxto) (CP.PHAR.535) (PDF)
- Mepolizumab (Nucala) (MDN.CP.PHAR.200) (PDF)
- Mercaptopurine (Purixan) (CP.PHAR.447) (PDF)
- Metformin ER (Fortamet, Glumetza) (CP.PMN.72) (PDF)
- Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex) (CP.PHAR.134) (PDF)
- Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) (CP.PHAR.238) (PDF)
- Methylnaltrexone Bromide (Relistor) (CP.PMN.169) (PDF)
- Methylphenidate (XR and transdermal) (Jornay PM, Daytrana) (MDN.CP.PMN.92) (PDF)
- Metreleptin (Myalept) (CP.PHAR.425) (PDF)
- Midostaurin (Rydapt) (CP.PHAR.344) (PDF)
- Mifepristone (Korlym) (CP.PHAR.101) (PDF)
- Migalastat (Galafold) (CP.PHAR.394) (PDF)
- Miglustat (Zavesca) (CP.PHAR.164) (PDF)
- Milnacipran (Savella) (CP.PMN.125) (PDF)
- Minocycline Micronized Foam (Amzeeq) (CP.PMN.242) (PDF)
- Mitapivat (Pyrukynd) (CP.PHAR.558) (PDF)
- Mitomycin for Pyelocalyceal Solution (Jelmyto) (CP.PHAR.495) (PDF)
- Mitoxantrone (Novantrone) (MDN.CP.PHAR.258) (PDF)
- Mobocertinib (Exkivity) (CP.PHAR.559) (PDF)
- Modafinil (Provigil) (MDN.CP.PMN.39) (PDF)
- Mogamulizumab-kpkc (Poteligeo) (CP.PHAR.139) (PDF)
- Moxetumomab pasudotox-tdfk (Lumoxiti) (CP.PHAR.398) (PDF)
- Nafarelin Acetate (Synarel) (CP.PHAR.174) (PDF)
- Naldemedine (Symproic) (MDN.CP.PMN.112) (PDF)
- Naloxegol (Movantik) (CP.PMN.171) (PDF)
- Natalizumab (Tysabri) (MDN.CP.PHAR.259) (PDF)
- Naxitamab-gqgk (Danyelza) (CP.PHAR.523) (PDF)
- Necitumumab (Portrazza) (CP.PHAR.320) (PDF)
- Neratinib (Nerlynx) (CP.PHAR.365) (PDF)
- Netarsudil (Rhopressa), Netarsudil/Latanoprost (Rocklatan) (CP.PMN.118) (PDF)
- Nifurtimox (Lampit) (CP.PMN.256) (PDF)
- Nilotinib (Tasigna) (CP.PHAR.76) (PDF)
- Nintedanib (Ofev) (CP.PHAR.285) (PDF)
- Niraparib (Zejula) (CP.PHAR.408) (PDF)
- Nitisinone (Nityr, Orfadin) (CP.PHAR.132) (PDF)
- Nivolumab (Opdivo) (CP.PHAR.121) (PDF)
- Nivolumab and Relatlimab (Opdualag) (CP.PHAR.588) (PDF)
- No Coverage Criteria (MDN.CP.PMN.255) (PDF)
- No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update (CP.PMN.255) (PDF)
- Non-Preferred Blood Glucose Monitors/Test Strips (MDN.CP.PMN.215) (PDF)
- Nusinersen (Spinraza) (MDN.CP.PHAR.327) (PDF)
- Obeticholic Acid (Ocaliva) (CP.PHAR.287) (PDF)
- Obinutuzumab (Gazyva (CP.PHAR.305) (PDF)
- Ocrelizumab (Ocrevus) (MDN.CP.PHAR.335) (PDF)
- Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Bynfezia, Mycapssa) (CP.PHAR.40) (PDF)
- Odevixibat (Bylvay) (CP.PHAR.528) (PDF)
- Ofatumumab (Arzerra, Kesimpta) (MDN.CP.PHAR.306) (PDF)
- Off-Label Use (CP.PMN.53) (PDF)
- Olanzapine/Samidorphan (Lybalvi) (CP.PMN.265) (PDF)
- Olaparib (Lynparza) (CP.PHAR.360) (PDF)
- Omacetaxine (Synribo (CP.PHAR.108) (PDF)
- Omadacycline (Nuzyra) (CP.PMN.188) (PDF)
- Omega-3-Acid Ethyl Esters (Lovaza) (CP.PMN.52) (PDF)
- OnabotulinumtoxinA (Botox) (CP.PHAR.232) (PDF)
- Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (CP.PHAR.536) (PDF)
- Opicapone (Ongentys) (MDN.CP.PMN.245) (PDF)
- Opioid Analgesics* (MDN.CP.PMN.97) (PDF)
- Osilodrostat (Isturisa) (CP.PHAR.487) (PDF)
- Osimertinib (Tagrisso) (CP.PHAR.294) (PDF)
- Ospemifene (Osphena) (CP.PMN.168) (PDF)
- Ozanimod (Zeposia) (MDN.CP.PHAR.462) (PDF)
- Ozenoxacin (Xepi) (CP.PMN.119) (PDF)
- Paclitaxel, Protein-Bound (Abraxane) (CP.PHAR.176) (PDF)
- Palbociclib (Ibrance) (CP.PHAR.125) (PDF)
- Palivizumab (Synagis) (CP.PHAR.16) (PDF)
- Panitumumab (Vectibix) (CP.PHAR.321) (PDF)
- Panobinostat (Farydak) (CP.PHAR.382) (PDF)
- Parathyroid Hormone (Natpara) (CP.PHAR.282) (PDF)
- Paricalcitol Injection (Zemplar) (CP.PHAR.270) (PDF)
- Pasireotide (Signifor, Signifor LAR) (CP.PHAR.332) (PDF)
- Patiromer (Veltassa) (CP.PMN.205) (PDF)
- Patisiran (Onpattro) (CP.PHAR.395) (PDF)
- Pazopanib (Votrient) (CP.PHAR.81) (PDF)
- Peanut Allergen Powder-dnfp (Palforzia) (CP.PMN.220) (PDF)
- Pegaspargase (Oncaspar), Calaspargase Pegol-mknl (Asparlas) (CP.PHAR.353) (PDF)
- Pegcetacoplan (Empaveli) (CP.PHAR.524) (PDF)
- Pegfilgrastim (Neulasta, Neulasta Onpro), Pegfilgrastim-jmdb (Fulphila), Pegfilgrastim-pbbk (Fylnetra), Pegfilgrastim-apgf (Nyvepria), Eflapegrastim-xnst (Rolvedon), Pegfilgrastim-fpgk (Stimufend), Pegfilgrastim-apgf (Nyvepria), Pegfilgrastim-cbqv (Udenyca), Pegfilgrastim-bmez (Ziextenzo) (MDN.CP.PHAR.296) (PDF)
- Peginterferon Alfa-2a,b (Pegasys, PegIntron, Sylatron (CP.PHAR.89) (PDF)
- Peginterferon Beta-1a (Plegridy) (MDN.CP.PHAR.271) (PDF)
- Pegloticase (Krystexxa) (CP.PHAR.115) (PDF)
- Pegvaliase-pqpz (Palynziq) (CP.PHAR.140) (PDF)
- Pegvisomant (Somavert) (CP.PHAR.389) (PDF)
- Pembrolizumab (Keytruda) (CP.PHAR.322) (PDF)
- Pemetrexed (Alimta, Pemfexy) (CP.PHAR.368) (PDF)
- Pemigatinib (Pemazyre) (CP.PHAR.496) (PDF)
- Pertuzumab (Perjeta) (CP.PHAR.227) (PDF)
- Pertuzumab/Trastuzumab/Hyaluronidase-zzxf (Phesgo) (CP.PHAR.501) (PDF)
- Pexidartinib (Turalio) (CP.PHAR.436) (PDF)
- Physician's Office Lab Testing (CC.PP.055) (PDF)
- Pilocarpine (Vuity) (CP.PMN.270) (PDF)
- Pimavanserin (Nuplazid) (CP.PMN.140) (PDF)
- Pirfenidone (Esbriet) (CP.PHAR.286) (PDF)
- Pitolisant (Wakix) (MDN.CP.PMN.221) (PDF)
- Plasminogen, human-tvmh (Ryplazim) (CP.PHAR.513) (PDF)
- Plecanatide (Trulance) (MDN.CP.PMN.87) (PDF)
- Plerixafor (Mozobil) (CP.PHAR.323) (PDF)
- Polatuzumab Vedotin-piiq (Polivy) (CP.PHAR.433) (PDF)
- Pomalidomide (Pomalyst) (CP.PHAR.116) (PDF)
- Ponatinib (Iclusig) (CP.PHAR.112) (PDF)
- Ponesimod (Ponvory) (MDN.CP.PHAR.537) (PDF)
- PPI Compounding Kits (MDN.CP.PMN.350) (PDF)
- Pralatrexate (Folotyn) (CP.PHAR.313) (PDF)
- Pralsetinib (Gavreto) (CP.PHAR.514) (PDF)
- Prasterone (Intrarosa) (CP.PMN.99) (PDF)
- Pretomanid (CP.PMN.222) (PDF)
- Propranolol HCl Oral Solution (Hemangeol) (MDN.CP.PMN.58) (PDF)
- Pyrimethamine (Daraprim) (CP.PMN.44) (PDF)
- Ramelteon (Rozerem) (CP.PMN.173) (PDF)
- Ramucirumab (Cyramza) (CP.PHAR.119) (PDF)
- Ranibizumab (Byooviz, Lucentis, Susvimo) (CP.PHAR.186) (PDF)
- Ravulizumab-cwvz (Ultomiris) (CP.PHAR.415) (PDF)
- Regorafenib (Stivarga) (CP.PHAR.107) (PDF)
- Relugolix (Orgovyx), Relugolix/Estradiol/Norethinedrone (Myfembree) (CP.PHAR.529) (PDF)
- Repository Corticotropin Injection (H.P. Acthar Gel, Purified Cortrophin Gel) (CP.PHAR.168) (PDF)
- Reslizumab (Cinqair) (MDN.CP.PHAR.223) (PDF)
- Respiratory syncytial virus vaccine (Abrysvo, Arexvy) (MDN.CP.PHAR.658) (PDF)
- Request for Medically Necessary Drug Not on the PDL (CP.PMN.16) (PDF)
- Ribociclib (Kisqali), Ribociclib/Letrozole (Kisqali Femara) (CP.PHAR.334) (PDF)
- Rifaximin (Xifaxan) (CP.PMN.47) (PDF)
- Rilonacept (Arcalyst) (CP.PHAR.266) (PDF)
- RimabotulinumtoxinB (Myobloc) (CP.PHAR.233) (PDF)
- Rimegepant (Nurtec ODT) (MDN.CP.PHAR.490) (PDF)
- Riociguat (Adempas) (CP.PHAR.195) (PDF)
- Ripretinib (Qinlock) (CP.PHAR.502) (PDF)
- Risankizumab-rzaa (Skyrizi) (MDN.CP.PHAR.426) (PDF)
- Risdiplam (Evrysdi) (CP.PHAR.477) (PDF)
- Risedronate (Actonel, Atelvia) (CP.PMN.100) (PDF)
- Rituximab (Rituxan), Rituximab-arrx (Riabni), Rituximab-pvvr (Ruxience), Rituximab-abbs (Truxima), Rituximab-Hyaluronidase (Rituxan Hycela) (CP.PHAR.260) (PDF)
- Rivaroxaban (Xarelto) (MDN.CP.PMN.247) (PDF)
- Roflumilast (Daliresp) (CP.PMN.46) (PDF)
- Rolapitant (Varubi) (CP.PMN.102) (PDF)
- Romidepsin (Istodax) (CP.PHAR.314) (PDF)
- Romiplostim (Nplate) (CP.PHAR.179) (PDF)
- Romosozumab-aqqg (Evenity) (CP.PHAR.428) (PDF)
- Ropeginterferon Alfa-2b-njft (BESREMi) (CP.PHAR.570) (PDF)
- Rucaparib (Rubraca) (CP.PHAR.350) (PDF)
- Ruxolitinib (Jakafi, Opzelura) (CP.PHAR.98) (PDF)
- Sacituzumab Govitecan-hziy (Trodelvy) (CP.PHAR.475) (PDF)
- Sapropterin Dihydrochloride (Kuvan) (CP.PHAR.43) (PDF)
- Sarilumab (Kevzara) (CP.PHAR.346) (PDF)
- Satralizumab-mwge (Enspryng) (CP.463) (PDF)
- Sebelipase Alfa (Kanuma) (CP.PHAR.159) (PDF)
- Secukinumab (Cosentyx) (MDN.CP.PHAR.261) (PDF)
- Selexipag (Uptravi) (CP.PHAR.196) (PDF)
- Selinexor (Xpovio) (CP.PHAR.431) (PDF)
- Selpercatinib (Retevmo) (CP.PHAR.478) (PDF)
- Selumetinib (Koselugo) (CP.PHAR.464) (PDF)
- Short Ragweed Pollen Allergen Extract (Ragwitek) (CP.PMN.83) (PDF)
- Sildenafil (Revatio, Liqrev) (MDN.CP.PHAR.197) (PDF)
- Siponimod (Mayzent) (MDN.CP.PHAR.427) (PDF)
- Sipuleucel-T (Provenge) (CP.PHAR.120) (PDF)
- Sirolimus Protein-Bound Particles (Fyarro) (CP.PHAR.574) (PDF)
- Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors (CP.PMN.14) (PDF)
- Sodium Oxybate (Xyrem) and Calcium, Magnesium, Potassium, and Sodium Oxybate (Xywav) (MDN.CP.PMN.42) (PDF)
- Sodium Phenylbutyrate (Buphenyl) (CP.PHAR.208) (PDF)
- Sodium Zirconium Cyclosilicate (Lokelma) (CP.PMN.163) (PDF)
- Solriamfetol (Sunosi) (CP.PMN.209) (PDF)
- Sonidegib (Odomzo) (CP.PHAR.272) (PDF)
- Sorafenib (Nexavar) (CP.PHAR.69) (PDF)
- Sotorasib (Lumakras) (CP.PHAR.549) (PDF)
- SSRI/SNRI Duplicate Therapy (CP.PMN.60) (PDF)
- Sunitinib (Sutent) (CP.PHAR.73) (PDF)
- Sutimlimab-jome (Enjaymo) (CP.PHAR.503) (PDF)
- Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract (Oralair) (CP.PMN.85) (PDF)
- Tadalafil (Adcirca, Alyq, Tadliq) (MDN.CP.PHAR.198) (PDF)
- Tadalafil BPH - ED (Cialis) (CP.PMN.132) (PDF)
- Tafamidis (Vyndaqel, Vyndamax) (CP.PHAR.432) (PDF)
- Tafasitamab-cxix (Monjuvi) (CP.PHAR.508) (PDF)
- Talazoparib (Talzenna) (CP.PHAR.409) (PDF)
- Taliglucerase Alfa (Elelyso) (CP.PHAR.157) (PDF)
- Talimogene laherepvec (Imlygic) (CP.PHAR.542) (PDF)
- Tasimelteon (Hetlioz, Hetlioz LQ) (CP.PMN.104) (PDF)
- Tazemetostat (Tazverik) (CP.PHAR.452) (PDF)
- Tebentafusp-tebn (Kimmtrak) (CP.PHAR.575) (PDF)
- Tedizolid (Sivextro) (CP.PMN.62) (PDF)
- Teduglutide (Gattex) (CP.PHAR.114) (PDF)
- Telotristat Ethyl (Xermelo) (CP.PHAR.337) (PDF)
- Temozolomide (Temodar) (CP.PHAR.77) (PDF)
- Temsirolimus (Torisel) (CP.PHAR.324) (PDF)
- Tenofovir Alafenamide Fumarate (Vemlidy) (CP.PMN.268) (PDF)
- Tepotinib (Tepmetko) (CP.PHAR.530) (PDF)
- Teprotumumab (Tepezza) (CP.PHAR.465) (PDF)
- Teriflunomide (Aubagio) (MDN.CP.PHAR.262) (PDF)
- Teriparatide (Forteo) (CP.PHAR.188) (PDF)
- Tesamorelin (Egrifta SV) (CP.PHAR.109) (PDF)
- Testosterone (MDN.CP.PMN.354) (PDF)
- Tetrabenazine (Xenazine) (CP.PHAR.92) (PDF)
- Tezacaftor/Ivacaftor; Ivacaftor (Symdeko) (CP.PHAR.377) (PDF)
- Thalidomide (Thalomid) (CP.PHAR.78) (PDF)
- Thioguanine (Tabloid) (CP.PHAR.437) (PDF)
- Thyrotropin Alfa (Thyrogen) (CP.PHAR.95) (PDF)
- Tildrakizumab-asmn (Ilumya) (MDN.CP.PHAR.386) (PDF)
- Timothy Grass Pollen Allergen Extract (Grastek) (CP.PMN.84) (PDF)
- Tisotumab vedotin-tftv (Tivdak) (CP.PHAR.561) (PDF)
- Tivozanib (Fotivda) (CP.PHAR.538) (PDF)
- Tobramycin (Bethkis, Kitabis Pak, TOBI, TOBI Podhaler) (MDN.CP.PHAR.211) (PDF)
- Tocilizumab (Actemra) (MDN.CP.PHAR.263) (PDF)
- Tofacitinib (Xeljanz, Xeljanz XR) (CP.PHAR.267) (PDF)
- Tolvaptan (Jynarque, Samsca) (MDN.CP.PHAR.27) (PDF)
- Topical Immunomodulators (MDN.CP.PMN.107) (PDF)
- Topotecan (Hycamtin) (CP.PHAR.64) (PDF)
- Toremifene (Fareston) (CP.PMN.126) (PDF)
- Trabectedin (Yondelis) (CP.PHAR.204) (PDF)
- Trametinib (Mekinist) (CP.PHAR.240) (PDF)
- Trastuzumab/Biosimilars, Trastuzumab-Hyaluronidase (CP.PHAR.228) (PDF)
- Treprostinil (Orenitram, Remodulin, Tyvaso, Tyvaso DPI) (MDN.CP.PHAR.199) (PDF)
- Triamcinolone ER Injection (Zilretta) (CP.PHAR.371) (PDF)
- Trientine (Syprine) (CP.PHAR.438) (PDF)
- Trifluridine/Tipiracil (Lonsurf) (CP.PHAR.383) (PDF)
- Triheptanoin (Dojolvi) (CP.PHAR.509) (PDF)
- Triptorelin Pamoate (Trelstar, Triptodur) (CP.PHAR.175) (PDF)
- Tucatinib (Tukysa) (CP.PHAR.497) (PDF)
- Ubrogepant (Ubrelvy) (MDN.CP.PHAR.476) (PDF)
- Umbralisib (Ukoniq) (CP.PHAR.531) (PDF)
- Upadacitinib (Rinvoq) (MDN.CP.PHAR.443) (PDF)
- Ustekinumab (Stelara), Ustekinumab-aekn (Selarsdi), Ustekinumab-auub (Wezlana) (MDN.CP.PHAR.264) (PDF)
- Valbenazine (Ingrezza) (MDN.CP.PHAR.340) (PDF)
- Valrubicin (Valstar) (CP.PHAR.439) (PDF)
- Vandetanib (Caprelsa) (CP.PHAR.80) (PDF)
- Vedolizumab (Entyvio) (MDN.CP.PHAR.265) (PDF)
- Velaglucerase Alfa (VPRIV) (CP.PHAR.163) (PDF)
- Vemurafenib (Zelboraf) (CP.PHAR.91) (PDF)
- Venetoclax (Venclexta) (CP.PHAR.129) (PDF)
- Vericiguat (Verquvo®) (MDN.CP.PMN.301) (PDF)
- Verteporfin (Visudyne) (CP.PHAR.187) (PDF)
- Vestronidase alfa-vjbk (Mepsevii) (CP.PHAR.374) (PDF)
- Vilazodone (Viibryd) (CP.PMN.145) (PDF)
- Viltolarsen (Viltepso) (MDN.CP.PHAR.484) (PDF)
- Vincristine Sulfate Liposome Injection (Marqibo) (CP.PHAR.315) (PDF)
- Vismodegib (Erivedge) (CP.PHAR.273) (PDF)
- Voclosporin (Lupkynis) (CP.PHAR.504) (PDF)
- Voretigene Neparvovec-rzyl (Luxturna) (CP.PHAR.372) (PDF)
- Vorinostat (Zolinza) (CP.PHAR.83) (PDF)
- Vortioxetine (Trintellix) (CP.PMN.65) (PDF)
- Vosoritide (Voxzogo) (CP.PHAR.525) (PDF)
- Voxelotor (Oxbryta) (CP.PHAR.451) (PDF)
- Zanubrutinib (Brukinsa) (CP.PHAR.467) (PDF)
- Ziv-aflibercept (Zaltrap) (CP.PHAR.325) (PDF)
- Zoledronic Acid (Reclast, Zometa) (CP.PHAR.59) (PDF)
- Zolpidem Tartrate (Edluar, Intermezzo, Zolpimist) (CP.PMN.172) (PDF)
Payment Policies
Payment policies are guidelines to assist in administering payment rules based on generally accepted principles of correct coding. They help identify whether healthcare services are correctly coded for reimbursement. Each payment rule is sourced by a generally accepted coding principle, including (but not limited to) claims processing guidelines referenced by: the Centers for Medicare and Medicaid Services (CMS), Publication 100-04, Claims Processing Manual for physicians/non-physician practitioners, the CMS National Correct Coding Initiative policy manual, Current Procedural Technology guidance published by the American Medical Association (AMA) for reporting medical procedures and services, health plan clinical policies and state-specific claims reimbursement guidance.
Review the Provider Manual for additional information about Meridian Billing and Payment policies.
- 25-hydroxyvitamin D Testing in Children and Adolescents (PDF)
- 30 Day Readmission (PDF)
- Allergy Testing and Therapy (PDF)
- Bronchial Thermoplasty (PDF)
- Cardiac Biomarker Testing (PDF)
- Clean Claim Reviews (PDF)
- Cost to Charge Adjustments on Clean Claim Reviews (PDF)
- Unbundling Adjustments on Clean Claim Reviews (PDF)
- Code Editing Overview (PDF)
- Concert Laboratory Payment Policy (PDF)
- Digital EEG Spike Analysis (PDF)
- EEG in the Evaluation of Headache (PDF)
- Endometrial Ablation (PDF)
- Evoked Potential Testing (PDF)
- Helicobacter Pylori Serology Testing (PDF)
- Laser Therapy for Skin Conditions (PDF)
- Leveling of Emergency Room Services (PDF)
- Measurement of Serum 1,25-dihydroxyvitamin D (PDF)
- Multiple Procedure Payment Reduction (MPPR) for Therapeutic Services (PDF)
- Multiple Procedure Payment Reduction (MPPR) for Diagnostic Cardiovascular Procedures (PDF)
- Multiple Procedure Reduction: Ophthalmology (PDF)
- Non-obstetrical and Obstetrical Transabdominal and Transvaginal Ultrasounds (PDF)
- Physician’s Consultation Services (PDF)
- Problem Oriented Visits Billed with Preventative Visits (PDF)
- Problem Oriented Visits Billed with Surgical Procedures (PDF)
- Renal Hemodialysis (PDF)
- Robotic Surgery (PDF)
- Sepsis Diagnosis (PDF)
- Severe Malnutrition (PDF)
- Sleep Studies Place of Service (PDF)
- Thyroid Hormones and Insulin Testing in Pediatrics (PDF)
- Ultrasound in Pregnancy (PDF)
- Urine Specimen Validity Testing (PDF)
- Urodynamic Testing (PDF)
- Wheelchairs and Accessories (PDF)
- Wheelchair Seating (PDF)